Search research articles
Contact Us
Filters
Showing results (81-90 of 128) with videos related to
Page
of 13
Sort By:
The Canadian Journal of Addiction
|
November 10, 2018
Large Variation in Provincial Guidelines for Urine Drug Screening during Opioid Agonist Treatment in Canada
Eloise Moss, Jasmine McEachern, Lauren Adye-White, et al.
Canadian Journal of Physiology and Pharmacology
|
March 23, 2011
Enalapril decreases cardiac mass and fetal gene expression without affecting the expression of endothelin-1, transforming growth factor β-1, or cardiotrophin-1 in the healthy normotensive rat
Katarina Mackovicova, Andrea Gazova, Dana Kucerova, et al.
The International Journal on Drug Policy
|
December 15, 2018
Lacking evidence for the association between frequent urine drug screening and health outcomes of persons on opioid agonist therapy
Jasmine McEachern, Lauren Adye-White, Kelsey C Priest, et al.
European Journal of Pharmacology
|
September 5, 2016
Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat
Hana Cernecka, Gabriel Doka, Jasna Srankova, et al.
European Journal of Heart Failure
|
January 27, 2009
Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function
Peter Krenek, Jana Kmecova, Dana Kucerova, et al.
Pathology, Research and Practice
|
July 4, 2012
Glucose and blood pressure lowering effects of Pycnogenol® are inefficient to prevent prolongation of QT interval in experimental diabetic cardiomyopathy
Stanislava Jankyova, Jana Kmecova, Hana Cernecka, et al.
Basic & Clinical Pharmacology & Toxicology
|
April 14, 2015
l-Arginine Attenuates Cardiac Dysfunction, But Further Down-Regulates α-Myosin Heavy Chain Expression in Isoproterenol-Induced Cardiomyopathy
Eva Kralova, Gabriel Doka, Lenka Pivackova, et al.
Drug and Alcohol Dependence
|
April 1, 2018
Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada
Jan Klimas, Ekaterina Nosova, Eugenia Socías, et al.
Molecular and Cellular Biochemistry
|
March 18, 2017
Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy
Gabriel Doka, Eva Malikova, Kristina Galkova, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
November 8, 2021
Pioglitazone restores phosphorylation of downregulated caveolin-1 in right ventricle of monocrotaline-induced pulmonary hypertension
Eva Malikova, Zuzana Kmecova, Gabriel Doka, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 128) with videos related to
Sort By:
Page
of 13
The Canadian Journal of Addiction
|
November 10, 2018
Large Variation in Provincial Guidelines for Urine Drug Screening during Opioid Agonist Treatment in Canada
Eloise Moss, Jasmine McEachern, Lauren Adye-White, et al.
Canadian Journal of Physiology and Pharmacology
|
March 23, 2011
Enalapril decreases cardiac mass and fetal gene expression without affecting the expression of endothelin-1, transforming growth factor β-1, or cardiotrophin-1 in the healthy normotensive rat
Katarina Mackovicova, Andrea Gazova, Dana Kucerova, et al.
The International Journal on Drug Policy
|
December 15, 2018
Lacking evidence for the association between frequent urine drug screening and health outcomes of persons on opioid agonist therapy
Jasmine McEachern, Lauren Adye-White, Kelsey C Priest, et al.
European Journal of Pharmacology
|
September 5, 2016
Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat
Hana Cernecka, Gabriel Doka, Jasna Srankova, et al.
European Journal of Heart Failure
|
January 27, 2009
Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function
Peter Krenek, Jana Kmecova, Dana Kucerova, et al.
Pathology, Research and Practice
|
July 4, 2012
Glucose and blood pressure lowering effects of Pycnogenol® are inefficient to prevent prolongation of QT interval in experimental diabetic cardiomyopathy
Stanislava Jankyova, Jana Kmecova, Hana Cernecka, et al.
Basic & Clinical Pharmacology & Toxicology
|
April 14, 2015
l-Arginine Attenuates Cardiac Dysfunction, But Further Down-Regulates α-Myosin Heavy Chain Expression in Isoproterenol-Induced Cardiomyopathy
Eva Kralova, Gabriel Doka, Lenka Pivackova, et al.
Drug and Alcohol Dependence
|
April 1, 2018
Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada
Jan Klimas, Ekaterina Nosova, Eugenia Socías, et al.
Molecular and Cellular Biochemistry
|
March 18, 2017
Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy
Gabriel Doka, Eva Malikova, Kristina Galkova, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
November 8, 2021
Pioglitazone restores phosphorylation of downregulated caveolin-1 in right ventricle of monocrotaline-induced pulmonary hypertension
Eva Malikova, Zuzana Kmecova, Gabriel Doka, et al.
Page
of 13